We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

69 hedge funds and large institutions have $33.4M invested in Spectrum Pharmaceuticals Inc in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

304% more call options, than puts

Call options by funds: $457K | Put options by funds: $113K

100% more capital invested

Capital invested by funds: $16.7M → $33.4M (+$16.8M)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

1% less funds holding

Funds holding: 70 → 69 (-1)

Holders
69
Holders Change
-1
Holders Change %
-1.43%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
17
Closed
9
Calls
$457K
Puts
$113K
Net Calls
+$344K
Net Calls Change
+$148K

Top Buyers

Rank Fund Capital Flow
1
SIG
Sargent Investment Group
Maryland
+$467K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$275K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$179K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$114K
5
BCM
Bridgeway Capital Management
Texas
+$109K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$396K
2
Millennium Management
Millennium Management
New York
-$385K
3
BlackRock
BlackRock
New York
-$311K
4
AC
Armistice Capital
New York
-$219K
5
Citadel Advisors
Citadel Advisors
Florida
-$216K
Name Holding Trade Value Shares
Change 		Change in
Stake
MWM
51
Mission Wealth Management
California
$7.5K – – –
NFC
52
Northeast Financial Consultants
Connecticut
$7.5K – – –
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$5K +$4.81K +6,594 +911%
TWM
54
Tradition Wealth Management
Minnesota
$4K +$3.76K +5,148 New
Fidelity Investments
55
Fidelity Investments
Massachusetts
$3.57K -$410 -562 -11%
JP Morgan Chase
56
JP Morgan Chase
New York
$3K – – –
UBS Group
57
UBS Group
Switzerland
$2.55K -$217 -298 -8%
KFI
58
Key Financial Inc
Pennsylvania
$1.88K – – –
SPIA
59
Steward Partners Investment Advisory
New York
$1.69K – – –
FDCDDQ
60
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.2K – – –
AF
61
Allworth Financial
California
$1.04K +$146 +200 +17%
FWM
62
Focused Wealth Management
New York
$600 – – –
UB
63
UMB Bank
Missouri
$150 – – –
KM
64
Kalos Management
Georgia
$150 +$146 +200 New
TWA
65
TCI Wealth Advisors
Arizona
$75 – – –
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$20 -$2.03K -2,777 -99%
LC
67
Lindbrook Capital
California
$1 – – –
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
– -$396K -1,073,491 Closed
Citadel Advisors
69
Citadel Advisors
Florida
– -$216K -296,392 Closed
GCP
70
GSA Capital Partners
United Kingdom
– -$22K -59,677 Closed
E
71
Ergoteles
New York
– -$18.9K -51,196 Closed
CSS
72
Cubist Systematic Strategies
Connecticut
– -$6.03K -16,362 Closed
Qube Research & Technologies (QRT)
73
Qube Research & Technologies (QRT)
United Kingdom
– -$4.64K -12,582 Closed
TRCT
74
Tower Research Capital (TRC)
New York
– -$8.5K -11,648 -100%
Vontobel Holding
75
Vontobel Holding
Switzerland
– -$3.69K -10,000 Closed
1 2
3
4

SPPI Hedge Fund Activity: Q1 2023 in Review

69 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2023, worth a combined $33.4M — up 100% from $16.7M a quarter earlier.

Fund positioning in SPPI was balanced in Q1 2023: 9 funds opened new positions, 9 closed out, 17 added to existing stakes and 17 trimmed.

The largest buyer was Sargent Investment Group, adding an estimated $467K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $396K sold.

  • 69 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2023, down from 70 in Q4 2022.
  • Funds reported $33.4M of Spectrum Pharmaceuticals Inc stock for Q1 2023, up 100% quarter-over-quarter.
  • 9 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2023 and 9 closed out, a net change of 0 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2023 was Sargent Investment Group, an estimated $467K added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2023 was D.E. Shaw & Co, an estimated $396K sold.

Based on aggregated 13F filings for Q1 2023.